ML18205A629
| ML18205A629 | |
| Person / Time | |
|---|---|
| Site: | 03014529 |
| Issue date: | 07/11/2018 |
| From: | Simmons M R NRC Region 4 |
| To: | Straub Clinic & Hosp |
| References | |
| 608699 | |
| Download: ML18205A629 (3) | |
Text
U.S. NUCLEAR REGULATORY COMMISSIONMATERIALS LICENSE NRC FORM 374PAGE OF13 Corrected Copy Amendment No. 31 P AGESPursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s) and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below.
Licensee Honolulu, HI 96813 2.888 South King Street Department of Nuclear Medicine 1.Straub Clinic & Hospital 4.Expiration Date:
October 31, 2025 Docket No.:
5.030-14529 License number: 53-18126-01 is amended in its entirety to read as
follows: Reference No.:
3.In accordance with email dated
April 12, 2018.
6.7.8.Byproduct, source, and/or special nuclear material Chemical and/or physical form Maximum amount that licensee
may possess at any one time
under this license 9.Authorized use A.A.A.A.For use in uptake, dilution and excretion studies permitted by 10 CFR
35.100.Any As Needed Any byproduct material
permitted by 10 CFR
35.100 B.B.B.B.For use in imaging and localization
studies permitted by 10 CFR 35.200.
Any As Needed Any byproduct material
permitted by 10 CFR
35.200 C.C.C.C.For any use permitted by 10 CFR
35.300.Any 1 curie total Any byproduct material
permitted by 10 CFR 35.300 D.D.D.D.For use in in-vitro studies.
Prepackaged Kits 5 millicuries total Any byproduct material permitted by 10 CFR 31.1 1 E.E.E.E.To be used for dose calibration checks and calibrations and quality assurance
testing.Liquid (IDEC Pharmaceuticals
Zevalin,)Not to exceed 2 sources, 110 millicuries total activity Yttrium-90 License Number Docket or Reference NumberU.S. NUCLEAR REGULATORY COMMISSION NRC FORM 374AMATERIALS LICENSESUPPLEMENTARY SHEETPAGES OFPAGE32 53-18126-01 030-14529 (Corrected Copy)
Amendment No. 31 CONDITIONS 10.Licensed material may be used or stored only at the licensee's facilities located at 888 South King Street, Honolulu, Hawaii (island of Oahu).
1 1.The Radiation Safety Officer for this license is Ronald W. Frick, M.S., CHP, DABR.
12.Licensed material shall only be used by, or under the supervision of:
A.Individuals permitted to work as authorized users, authorized nuclear pharmacists, and/or authorized medical physicists, in accordance with 10 CFR 35.13 and 10 CFR 35.14.
B.The following individuals are authorized users for the material and medical uses as indicated:
Authorized User(M.D.,D.O.,etc.)
Material and Use Marc Coel, M.D.
35.100; 35.200; 35.300; 31.11 Brandon Itagaki, M.D.
35.100; 35.200 Shay J. Lee, M.D.
35.100; 35.200; 35.300Douglas A. Prager, M.D.
35.100; 35.200; 35.300Brian T. Sinclair, M.D.35.100; 35.200; 31.11Kristi Takaki, M.D.
35.100; 35.200 13.Sealed sources containing licensed material shall not be opened or sources removed from source holders by the licensee, except as specifically authorized.
14.In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licensed material to quantities below the limits specified in 10 CFR 30.72 which require consideration of the need for an emergency plan for responding to a release of licensed material.
License Number Docket or Reference NumberU.S. NUCLEAR REGULATORY COMMISSION NRC FORM 374AMATERIALS LICENSESUPPLEMENTARY SHEETPAGES OFPAGE33 53-18126-01 030-14529 (Corrected Copy)
Amendment No. 31 15.Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements, representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to
those procedures that are required to be submitted in accordance with the regulations. Additionally, this license condition does not limit the
licensee's ability to make changes to the radiation protection program as provided for in 10 CFR 35.26. The U.S. Nuclear Regulatory
Commission's regulations shall govern unless the statements, representations, and procedures in the licensee's application and
correspondence are more restrictive than the regulations.A.Letter with enclosures dated November 27, 2012 (ML12352A137)B.Application dated April 6, 2015 (ML15110A473)C.Letter dated October 8, 2015 (ML15288A424)FOR THE U.S. NUCLEAR REGULATORY COMMISSION By: Date: Region 4 Michelle R. Simmons July , 2018